Skip to content
10-Q

Quarterly Report

Rain Oncology Inc.

0001558370-22-017405

← back to feed
Filed
Nov 10, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 3, 2022 26.56M sh
Short Term Investments Q3 2022 · Sep 30, 2022 $50.87M
Short Term Investments Q3 2022 · Dec 31, 2021 $115.44M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $39.83M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $24.78M
Current Liabilities Q3 2022 · Sep 30, 2022 $13.01M
Current Liabilities Q3 2022 · Dec 31, 2021 $16.32M
Total Liabilities Q3 2022 · Sep 30, 2022 $13.23M
Total Liabilities Q3 2022 · Dec 31, 2021 $16.64M
Current Assets Q3 2022 · Sep 30, 2022 $93.75M
Current Assets Q3 2022 · Dec 31, 2021 $146.15M
Total Assets Q3 2022 · Sep 30, 2022 $94.64M
Total Assets Q3 2022 · Dec 31, 2021 $147.14M
Shares Diluted Q3 2022 · Sep 30, 2021 26.47M sh
Shares Diluted Q3 2022 · Sep 30, 2021 17.03M sh
Capex Q3 2022 · Sep 30, 2021 $128K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$27.7M
Stockholders Equity Q3 2022 · Sep 30, 2021 $147.28M
Stockholders Equity Q3 2022 · Jun 30, 2021 $164.83M
Stockholders Equity Q3 2022 · Mar 31, 2021 −$44.05M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$37.42M
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.70
Eps Diluted Q3 2022 · Sep 30, 2021 −$1.96
Eps Basic Q3 2022 · Sep 30, 2021 −$0.70
Eps Basic Q3 2022 · Sep 30, 2021 −$1.96
Sga Expense Q3 2022 · Sep 30, 2021 $3.15M
Sga Expense Q3 2022 · Sep 30, 2021 $7.33M
Rd Expense Q3 2022 · Sep 30, 2021 $15.28M
Rd Expense Q3 2022 · Sep 30, 2021 $26.1M
Net Income Q3 2022 · Sep 30, 2021 −$18.43M
Net Income Q3 2022 · Sep 30, 2021 −$33.41M
Net Income Q3 2022 · Jun 30, 2021 −$8.18M
Net Income Q3 2022 · Mar 31, 2021 −$6.8M
Operating Income Q3 2022 · Sep 30, 2021 −$18.44M
Operating Income Q3 2022 · Sep 30, 2021 −$33.44M